4.7 Article

Acute restraint stress augments the rewarding memory of cocaine through activation of α1 adrenoceptors in the medial prefrontal cortex of mice

Journal

NEUROPHARMACOLOGY
Volume 166, Issue -, Pages -

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neuropharm.2020.107968

Keywords

Cocaine; Medial prefrontal cortex; Noradrenaline; Stress; alpha(1) adrenoceptor; Conditioned place preference

Funding

  1. Japan Society for the Promotion of Science (JSPS) [18K06520, 18H02523]
  2. Hoansha Foundation
  3. Smoking Research Foundation
  4. Naito Foundation
  5. Grants-in-Aid for Scientific Research [18K06520, 18H02523] Funding Source: KAKEN

Ask authors/readers for more resources

Stress augments the rewarding memory of cocaine, which plays a critical role in inducing cocaine craving. However, the neurobiological mechanisms underlying the enhancing effect of stress remain unclear. Here, we show that noradrenaline (NA) transmission in the medial prefrontal cortex (mPFC) mediates stress-induced enhancement of cocaine craving. When mice were exposed to acute restraint stress immediately before the posttest session of the cocaine-induced conditioned place preference (CPP) paradigm, the CPP score was significantly higher than that in non-stressed mice. Because extracellular NA levels have been reported to be increased in the mPFC during stress exposure, we assessed the effects of NA on mPFC layer 5 pyramidal cell activity. Whole-cell recordings revealed that NA application induces depolarization and a concomitant increase in spontaneous excitatory postsynaptic currents (sEPSCs). The NA effects were inhibited by terazosin, but not by yohimbine or timolol, and the sEPSC increase was not observed in the presence of tetrodotoxin, suggesting the involvement of postsynaptic alpha(1), but not alpha(2) or beta, adrenoceptors in the NA effects. Additionally, intra-mPFC injection of terazosin before stress exposure attenuated the stress-induced increase in cocaine CPP. Intra-mPFC injection of phenylephrine, an alpha(1) adrenoceptor agonist, before the posttest session without stress exposure significantly enhanced cocaine CPP. Furthermore, chemogenetic suppression of mPFC pyramidal cells with inhibitory DREADD (designer receptors exclusively activated by designer drugs) also suppressed the stress-induced CPP enhancement. These findings suggest that the stress-induced increase in NA transmission activates mPFC Pyramidal cells via alpha(1) adrenoceptor stimulation, leading to enhancement of cocaine craving-related behavior.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Acetaminophen improves tardive akathisia induced by dopamine D2 receptor antagonists

Koki Nagaoka, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko

Summary: In this study, the researchers analyzed databases to find a drug that can be used together with dopamine D2 receptor antagonists to reduce the risk of akathisia. Acetaminophen was found to be the most effective drug in suppressing tardive akathisia. Experimental validation showed that chronic treatment of rats with haloperidol caused akathisia symptoms, while acute treatment with acetaminophen significantly attenuated these symptoms.

JOURNAL OF PHARMACOLOGICAL SCIENCES (2023)

Article Neurosciences

Role of neurotrophic and growth factors in the rapid and sustained antidepressant actions of ketamine

Satoshi Deyama, Katsuyuki Kaneda

Summary: The neurotrophic hypothesis of depression suggests that reduced levels of BDNF and VEGF are associated with depressive symptoms. Typical monoaminergic antidepressants can partially reverse these deficits by inducing the expression of BDNF and/or VEGF, but the effects are delayed. Ketamine, on the other hand, rapidly increases the release and/or expression of BDNF and VEGF, improving neuronal connectivity and neurogenesis, as well as leading to the sustained release of IGF-1, resulting in rapid and sustained antidepressant effects.

NEUROPHARMACOLOGY (2023)

Article Clinical Neurology

Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex

Satoshi Deyama, Shun Aoki, Rinako Sugie, Hayato Fukuda, Satoshi Shuto, Masabumi Minami, Katsuyuki Kaneda

Summary: The intranasal administration of RvE1, a compound with anti-inflammatory and immunomodulatory properties, has shown promising results in treating depression. This compound acts on the mPFC and dorsal DG brain regions, and its antidepressant effects are mediated by the regulation of BDNF/VEGF and mTORC1 signaling pathways.

NEUROTHERAPEUTICS (2023)

Article Neurosciences

Enhancement of adenosine A2A signaling improves dopamine D2 receptor antagonist-induced dyskinesia via β-arrestin signaling

Koki Nagaoka, Nozomi Asaoka, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko

Summary: Repeated administration of dopamine D-2 receptor antagonists for the treatment of psychosis often leads to tardive dyskinesia. This study found that activating adenosine A2A receptors in the striatum can alleviate dyskinetic symptoms caused by TD.

FRONTIERS IN NEUROSCIENCE (2023)

Article Immunology

Lisinopril prevents bullous pemphigoid induced by dipeptidyl peptidase 4 inhibitors via the Mas receptor pathway

Keisuke Nozawa, Takahide Suzuki, Gen Kayanuma, Hiroki Yamamoto, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko

Summary: Recent studies have found that DPP4 inhibitors increase the risk of bullous pemphigoid (BP), a common autoimmune blistering skin disease. The mechanisms behind this association are unclear, and there are currently no identified therapeutic targets for drug-induced BP. However, clinical data mining revealed that concomitant use of lisinopril, an angiotensin-converting enzyme inhibitor, significantly decreased the incidence of BP in patients receiving DPP4 inhibitors. In vitro experiments further showed that DPP4 inhibitors upregulated MMP9 and ACE2 mRNA expression, which play a role in the pathophysiology of BP, and that lisinopril and Mas receptor inhibitors could suppress this upregulation.

FRONTIERS IN IMMUNOLOGY (2023)

Article Public, Environmental & Occupational Health

Early Detection of Adverse Drug Reaction Signals by Association Rule Mining Using Large-Scale Administrative Claims Data

Hiroki Yamamoto, Gen Kayanuma, Takuya Nagashima, Chihiro Toda, Kazuki Nagayasu, Shuji Kaneko

Summary: This study aimed to identify methods for the early detection of a wide range of adverse drug reactions (ADRs). A data-mining approach using large-scale medical records was used, and association rule mining (ARM) was applied to patient symptoms and medications. The results showed that ARM of claims data may be effective in the early detection of a wide range of ADR signals.

DRUG SAFETY (2023)

Article Biochemistry & Molecular Biology

Peripheral Beta-2 Adrenergic Receptors Mediate the Sympathetic Efferent Activation from Central Nervous System to Splenocytes in a Mouse Model of Fibromyalgia

Shiori Yamashita, Naoki Dozono, Shota Tobori, Kazuki Nagayasu, Shuji Kaneko, Hisashi Shirakawa, Hiroshi Ueda

Summary: Abnormalities in the peripheral immune system are involved in the pathophysiology of fibromyalgia, and the activation of peripheral beta 2-adrenergic receptors plays an important role in the efferent pathway from the CNS to splenocytes in pain development. The administration of selective beta 2-blockers prevented the development but not the maintenance of pain-like behavior, and beta 2-blockade in donor mice eliminated pain reproduction in recipient mice injected with AcGP splenocytes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Cell Biology

Dorsal raphe serotonergic neurons preferentially reactivate dorsal dentate gyrus cell ensembles associated with positive experience

Yuma Nagai, Yuri Kisaka, Kento Nomura, Naoya Nishitani, Chihiro Andoh, Masashi Koda, Hiroyuki Kawai, Kaoru Seiriki, Kazuki Nagayasu, Atsushi Kasai, Hisashi Shirakawa, Takanobu Nakazawa, Hitoshi Hashimoto, Shuji Kaneko

Summary: Major depressive disorder (MDD) is a common mental illness, and serotonergic neurons play a crucial role in its pathophysiology and treatment. Recalling positive memories repeatedly is effective for MDD. This study found that activating 5-HT neurons can activate specific neuronal ensembles associated with positive memories, providing insights into the antidepressive effects of serotonin.

CELL REPORTS (2023)

Article Pharmacology & Pharmacy

Vitamin D supplementation is effective for olanzapine-induced dyslipidemia

Zijian Zhou, Takuya Nagashima, Chihiro Toda, Mone Kobayashi, Takahide Suzuki, Kazuki Nagayasu, Hisashi Shirakawa, Satoshi Asai, Shuji Kaneko

Summary: Olanzapine is an atypical antipsychotic drug used for schizophrenia. Vitamin D has been found to reduce the risk of olanzapine-induced dyslipidemia. By analyzing clinical data and conducting experiments, it was discovered that vitamin D improves dyslipidemia by inhibiting cholesterol biosynthesis. This clinical big-data-based drug repurposing approach provides a novel treatment with high clinical predictability and a well-defined molecular mechanism.

FRONTIERS IN PHARMACOLOGY (2023)

Article Pharmacology & Pharmacy

Increased expression of glutathione peroxidase 3 prevents tendinopathy by suppressing oxidative stress

Haruka Furuta, Mari Yamada, Takuya Nagashima, Shuichi Matsuda, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko

Summary: The short-term use of dexamethasone prevents fluoroquinolone-induced and age-related tendinopathy by suppressing oxidative stress through upregulation of the antioxidant enzyme glutathione peroxidase 3 (GPX3).

FRONTIERS IN PHARMACOLOGY (2023)

Article Neurosciences

Antidepressant-like effects of tomatidine and tomatine, steroidal alkaloids from unripe tomatoes, via activation of mTORC1 in the medial prefrontal cortex in lipopolysaccharide-induced depression model mice

Satoshi Deyama, Rinako Sugie, Masaki Tabata, Katsuyuki Kaneda

Summary: Tomatidine and tomatine exerted prophylactic and therapeutic antidepressant-like effects via mTORC1 activation in the mPFC, making them promising candidates for novel prophylactic and therapeutic agents for depression.

NUTRITIONAL NEUROSCIENCE (2023)

Article Pharmacology & Pharmacy

Specific Cellular Effects of Low Bortezomib Concentrations on Purified Cultures of Schwann Cells, Satellite Glial Cells, Macrophages, and Dorsal Root Ganglion Neurons

Zijian Zhou, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko

Summary: Low concentrations of bortezomib (BTZ) can induce changes in peripheral nervous system cells, including dedifferentiation of Schwann cells, increased GFAP levels in satellite glial cells, and decreased expression levels of sensor and transducer ion channels in dorsal root ganglion neurons. These findings contribute to a better understanding of the mechanisms underlying BTZ-induced peripheral neuropathy.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2023)

Article Neurosciences

Neuron-specific deletion of VEGF or its receptor Flk-1 occludes the antidepressant-like effects of desipramine and fluoxetine in mice

Satoshi Deyama, Xiao-Yuan Li, Ronald S. Duman

Summary: This study found that neuronal VEGF-Flk-1 signaling contributes to the antidepressant-like effects of conventional antidepressants.

NEUROPSYCHOPHARMACOLOGY REPORTS (2023)

Article Pharmacology & Pharmacy

Diff-ATAC-STARR-Seq: A Method for Genome-Wide Functional Screening of Enhancer Activity in Vivo

Kazuki Nagayasu, Chihiro Andoh, Hisashi Shirakawa, Shuji Kaneko

Summary: In this study, a novel method for genome-wide functional screening of enhancer activity in vivo with minimal handling was described. The method allows identification of enhancers with cell-type specific and brain-structure specific activity, which is helpful for cell-type specific manipulations.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2022)

Article Respiratory System

Analysis of real-world data and a mouse model indicates that pirfenidone causes pellagra

Koji Kuronuma, Natsumi Susai, Tomohiro Kuroita, Hiroki Yamamoto, Takeshi Yoshioka, Shuji Kaneko, Hirofumi Chiba

Summary: This study found that PFD may cause pellagra or pellagra-like symptoms such as photosensitivity. Experiments on mice confirmed this hypothesis and suggested that it may be mediated by the actions of NNMT. Urine analysis also supported this hypothesis.

ERJ OPEN RESEARCH (2022)

Correction Neurosciences

'The MK2 cascade regulates mGluR-dependent synaptic plasticity and reversal learning' (vol 155, pg 121, 2019)

Lucia Privitera, Ellen L. Hogg, Matthias Gaestel, Mark J. Wall, Sonia A. L. Correa

NEUROPHARMACOLOGY (2024)

Article Neurosciences

CREB-induced LINC00473 promotes chemoresistance to TMZ in glioblastoma by regulating O6-methylguanine-DNA-methyltransferase expression via CEBPα binding

Li-Ya Jiang, Guan-Hao Wang, Jing-Jiao Xu, Xiao-Li Li, Xiao-Yan Lin, Xiang Fang, Hong-Xu Zhang, Mei Feng, Chun-Ming Jiang

Summary: This study reveals the importance of LINC00473 in regulating temozolomide (TMZ) resistance in glioblastoma (GB) and its potential mechanism. By regulating the expression of CEBP alpha and MGMT, LINC00473 promotes the formation of chemoresistance. Furthermore, LINC00473 can transfer chemoresistance to adjacent sensitive cells through exosomes.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Mitochondrial malfunction mediates impaired cholinergic Ca2+signalling and submandibular salivary gland dysfunction in diabetes

Olga Kopach, Tetyana Pivneva, Nataliya Fedirko, Nana Voitenko

Summary: This study found that diabetic animals exhibit severe xerostomia characterized by reduced saliva flow rate, diminished total protein content, and decreased amylase activity. The impaired saliva production in diabetes is associated with reduced and delayed intracellular Ca2+ signals in submandibular acinar cells, caused by malfunctioning mitochondria. Targeting malfunctioning mitochondria may be a potential strategy for the treatment of diabetic xerostomia.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Non-consummatory behavior signals predict aversion-resistant alcohol drinking in head-fixed mice

Nicholas M. Timme, Cherish E. Ardinger, Seth D. C. Weir, Rachel Zelaya-Escobar, Rachel Kruger, Christopher C. Lapish

Summary: This study aimed to assess aversion-resistant drinking behavior in head-fixed mice and explore the relationship between non-consummatory behaviors and aversion-resistant drinking. The results showed that head-fixed mice exhibited heterogenous levels of aversion-resistant drinking and non-consummatory behaviors were related to the intensity of this behavior.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Daily methocinnamox treatment dose-dependently attenuates fentanyl self-administration in rhesus monkeys

David R. Maguire, Charles P. France

Summary: Methocinnamox (MCAM) is a novel, long-acting opioid receptor antagonist that effectively decreases fentanyl self-administration and prevents opioid overdose in monkeys. The study demonstrates the potential therapeutic utility of MCAM in the treatment of opioid use disorder.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Ventral hippocampus is more sensitive to fluoxetine-induced changes in extracellular 5-HT concentration, membrane 5-HT transporter level and immobility times

Xiang Li, Dan Feng, Shenglu Ma, Mingxing Li, Shulei Zhao, Man Tang

Summary: This study investigated the effects of fluoxetine on neurochemical, neurobiological, and neurobehavioral changes in different subregions of the hippocampus. The results showed that fluoxetine increased dialysate 5-HT, decreased membrane 5-HTT protein, and increased cytoplasmic fraction. Additionally, fluoxetine reduced immobility times in behavioral tests, with greater effects observed in the ventral subregion compared to the dorsal subregion.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Molecular mechanisms of cholinergic neurotransmission in visceral smooth muscles with a focus on receptor-operated TRPC4 channel and impairment of gastrointestinal motility by general anaesthetics and anxiolytics

Alexander V. Zholos, Mariia I. Melnyk, Dariia O. Dryn

Summary: Acetylcholine is an important neurotransmitter in visceral smooth muscles, activating M2 and M3 muscarinic receptors to cause smooth muscle excitation and contraction. This review focuses on the cellular and molecular mechanisms underlying acetylcholine-induced depolarisation and smooth muscle contraction, as well as the effects of anticholinergic drugs on gastrointestinal motility. The knowledge gained from recent studies has greatly expanded our understanding of these processes.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Methylone produces antidepressant-relevant actions and prosocial effects

Zhenlong Li, Hsien-Yu Peng, Chau-Shoun Lee, Tzer-Bin Lin, Ming-Chun Hsieh, Cheng-Yuan Lai, Han-Fang Wu, Lih-Chyang Chen, Mei-Ci Chen, Dylan Chou

Summary: Methylone shows significant efficacy in treating depression and social deficits, making it an ideal candidate for anti-depressant medication.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Fluoroethylnormemantine (FENM) shows synergistic protection in combination with a sigma-1 receptor agonist in a mouse model of Alzheimer's disease

Aline Freyssin, Allison Carles, Sarra Guehairia, Gilles Rubinstenn, Tangui Maurice

Summary: This study explores the potential of combining FENM and S1R agonists in the treatment of Alzheimer's disease. The results showed that most FENM-based combinations can protect against learning deficits caused by A beta 25-35, with better efficacy in short-term memory.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Sex-dependent effect of inflammatory pain on negative affective states is prevented by kappa opioid receptors blockade in the nucleus accumbens shell

J. D. Lorente, J. Cuitavi, L. Rullo, S. Candeletti, P. Romualdi, L. Hipolito

Summary: This study analyzed the effects of pain on negative affect in different sexes and time courses, as well as the involvement of the dynorphinergic and corticotropin releasing factor systems in these pain-related behaviors. The results showed sex and time-dependent anxiety- and anhedonia-like behaviors induced by pain in female rats. The recruitment of KOR/DYN in the NAc was identified as a key neurological substrate mediating pain-induced behavioral alterations.

NEUROPHARMACOLOGY (2024)

Article Neurosciences

Intranasal oxytocin alleviates comorbid depressive symptoms in neuropathic pain via elevating hippocampal BDNF production in both female and male mice

Rongjun Liu, Daofan Sun, Xiuzhong Xing, Qingge Chen, Bo Lu, Bo Meng, Hui Yuan, Lan Mo, Liufang Sheng, Jinwei Zheng, Qiusheng Wang, Junping Chen, Xiaowei Chen

Summary: The coexistence of pain and depression is frequently observed in patients with chronic pain and depression. Oxytocin, a neuropeptide, has been reported to relieve chronic pain and depressive symptoms. This study investigated the effect of intranasal oxytocin on neuropathic pain and comorbid depressive symptoms, and found that oxytocin attenuated depression-like behavior but did not alleviate mechanical hyperalgesia. The results suggest that intranasal oxytocin may have the potential to treat depressive symptoms in neuropathic pain patients.

NEUROPHARMACOLOGY (2024)